Prospective Multicenter Single-Arm Phase II Trial: Adebrelimab Plus Apatinib and Doxorubicin for First-Line Treatment of Advanced Soft Tissue Sarcoma

Authors
Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2026
This article has no abstract
Epistemonikos ID: 6d46ba06cffaa8cc4810c799b5be3db867a1271d
First added on: Sep 12, 2026